TWi T085 225 Pill - white capsule/oblong, 19mm
Pill with imprint TWi T085 225 is White, Capsule/Oblong and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by TWi Pharmaceuticals USA, Inc.
Propafenone is used in the treatment of Atrial Fibrillation; Wolff-Parkinson-White Syndrome; Atrial Flutter; Ventricular Tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TWi T085 225
Propafenone Hydrochloride Extended-Release
- Imprint
- TWi T085 225
- Strength
- 225 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TWi Pharmaceuticals USA, Inc.
- Manufacturer
- TWi Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 24979-0085 (Discontinued)
More about propafenone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (71)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.